Citation: Aa. Khan et al., 2 2-HYDROXY-3-ALKYL-1,4-NAPHTHOQUINONES WITH IN-VITRO AND IN-VIVO ACTIVITIES AGAINST TOXOPLASMA-GONDII, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2284-2289
Authors:
LUNDEN A
PARMLEY SF
BENGTSSON KL
ARAUJO FG
Citation: A. Lunden et al., USE OF A RECOMBINANT ANTIGEN, SAG2, EXPRESSED AS A GLUTATHIONE-S-TRANSFERASE FUSION PROTEIN TO IMMUNIZE MICE AGAINST TOXOPLASMA-GONDII, Parasitology research, 83(1), 1997, pp. 6-9
Authors:
SANTOS ACD
ARAUJO FG
DACRUZ AG
DEAZEVEDO MCC
Citation: Acd. Santos et al., DISTRIBUTION AND RELATIVE ABUNDANCE OF GE RREIDAE (OSTEICHTHYES, PERCIFORMES) IN THE SEPETIBA BAY, RJ, Arquivos de biologia e tecnologia, 40(3), 1997, pp. 672-686
Citation: Acd. Santos et Fg. Araujo, FEEDING-HABITS OF 3 GERREID FISHES (OSTEI CHTHYES, PERCIFORMES) IN THE SEPETIBA BAY, RJ, Arquivos de biologia e tecnologia, 40(2), 1997, pp. 359-368
Citation: Fg. Araujo et Mrf. Simoni, LENGTH-WEIGHT RELATIONSHIPS OF LAMBARI RABO VERMELHO (ASTYANAX-FASCIATUS PARAHYBAE) AND OF LAMBARI RABO AMARELO (ASTYANAX-BIMACULATUS) FROMTHE RIBEIRAO-DAS-LAJES RESERVOIR, RIO-DE-JANEIRO, BRAZIL, Arquivos de biologia e tecnologia, 40(2), 1997, pp. 453-458
Authors:
KHAN AA
SLIFER T
ARAUJO FG
POLZER RJ
REMINGTON JS
Citation: Aa. Khan et al., ACTIVITY OF TROVAFLOXACIN IN COMBINATION WITH OTHER DRUGS FOR TREATMENT OF ACUTE MURINE TOXOPLASMOSIS, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 893-897
Authors:
ARAUJO FG
KHAN AA
SLIFER TL
BRYSKIER A
REMINGTON JS
Citation: Fg. Araujo et al., THE KETOLIDE ANTIBIOTICS HMR-3647 AND HMR-3004 ARE ACTIVE AGAINST TOXOPLASMA-GONDII IN-VITRO AND IN MURINE MODELS OF INFECTION, Antimicrobial agents and chemotherapy, 41(10), 1997, pp. 2137-2140
Citation: Fg. Araujo et al., TREATMENT WITH INTERLEUKIN-12 IN COMBINATION WITH ATOVAQUONE OR CLINDAMYCIN SIGNIFICANTLY INCREASES SURVIVAL OF MICE WITH ACUTE TOXOPLASMOSIS, Antimicrobial agents and chemotherapy, 41(1), 1997, pp. 188-190
Authors:
HUNTER CA
ELLISNEYES LA
SLIFER T
KANALY S
GRUNIG G
FORT M
RENNICK D
ARAUJO FG
Citation: Ca. Hunter et al., IL-10 IS REQUIRED TO PREVENT IMMUNE HYPERACTIVITY DURING INFECTION WITH TRYPANOSOMA-CRUZI, The Journal of immunology, 158(7), 1997, pp. 3311-3316
Citation: Fg. Araujo et al., USE OF RIFABUTIN IN COMBINATION WITH ATOVAQUONE, CLINDAMYCIN, PYRIMETHAMINE, OR SULFADIAZINE FOR TREATMENT OF TOXOPLASMIC ENCEPHALITIS IN MICE, European journal of clinical microbiology & infectious diseases, 15(5), 1996, pp. 394-397
Citation: Fg. Araujo et al., RIFAPENTINE IS ACTIVE IN-VITRO AND IN-VIVO AGAINST TOXOPLASMA-GONDII, Antimicrobial agents and chemotherapy, 40(6), 1996, pp. 1335-1337
Authors:
CHIARI E
OLIVEIRA AB
PRADO MAF
ALVES RJ
GALVAO LMC
ARAUJO FG
Citation: E. Chiari et al., POTENTIAL USE OF WR6026 AS PROPHYLAXIS AGAINST TRANSFUSION-TRANSMITTED AMERICAN TRYPANOSOMIASIS, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 613-615
Citation: Fg. Araujo et T. Slifer, NONIONIC BLOCK-COPOLYMERS POTENTIATE ACTIVITIES OF DRUGS FOR TREATMENT OF INFECTIONS WITH TOXOPLASMA-GONDII, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2696-2701
Citation: Fg. Araujo et al., STRUCTURAL EVOLUTION OF A POROUS TYPE-VI SOL-GEL SILICA GLASS, Journal of non-crystalline solids, 185(1-2), 1995, pp. 41-48
Citation: Djp. Ferguson et al., AN ULTRASTRUCTURAL-STUDY OF THE EFFECT OF TREATMENT WITH ATOVAQUONE IN BRAINS OF MICE CHRONICALLY INFECTED WITH THE ME49 STRAIN OF TOXOPLASMA-GONDII, International journal of experimental pathology, 75(2), 1994, pp. 111-116
Citation: G. Harth et al., TRYPANOSOMA-CRUZI GLYCOPROTEIN OF M(R) 56,000 - CHARACTERIZATION AND ASSESSMENT OF ITS POTENTIAL TO PROTECT AGAINST FATAL PARASITE INFECTIONS, Molecular microbiology, 11(2), 1994, pp. 261-271
Citation: Djp. Ferguson et al., A MORPHOLOGICAL-STUDY OF CHRONIC CEREBRAL TOXOPLASMOSIS IN MICE - COMPARISON OF 4 DIFFERENT STRAINS OF TOXOPLASMA-GONDII, Parasitology research, 80(6), 1994, pp. 493-501
Citation: Mh. Beaman et al., PROTECTIVE RECONSTITUTION OF THE SCID MOUSE AGAINST REACTIVATION OF TOXOPLASMIC ENCEPHALITIS, The Journal of infectious diseases, 169(2), 1994, pp. 375-383
Citation: Fg. Araujo, CD4-LYMPHOCYTES ARE REQUIRED FOR DEVELOPMENT OF IMMUNITY AND TO PREVENT REACTIVATION OF INFECTION WITH TOXOPLASMA-GONDII (TG) IN SCID MICE(T), The Journal of immunology, 150(8), 1993, pp. 153-153
Citation: A. Lunden et al., IMMUNE-RESPONSES AND RESISTANCE TO TOXOPLASMA-GONDII IN MICE IMMUNIZED WITH ANTIGENS OF THE PARASITE INCORPORATED INTO IMMUNOSTIMULATING COMPLEXES, Infection and immunity, 61(6), 1993, pp. 2639-2643
Citation: Fg. Araujo et Js. Remington, RIFABUTIN IS EFFECTIVE FOR TREATMENT OF MURINE TOXOPLASMOSIS, Clinical research, 41(3), 1993, pp. 10000603-10000603